Phase II/III Trial of CPT-11/5-FU/l-LV (FOLFIRI) Versus CPT-11/TS-1 (IRIS) as Second Line Chemotherapy of Unresectable Colorectal Cancer.
Phase of Trial: Phase II/III
Latest Information Update: 20 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms FIRIS
- Sponsors Taiho Pharmaceutical
- 06 Jul 2011 Actual end date changed from Nov 2011 to Mar 2012 as reported by ClinicalTrials.gov.
- 07 Jun 2011 Primary endpoint 'Progression-free-survival-duration' has been met.
- 07 Jun 2011 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History